Atria Investments Inc Sells 5,170 Shares of Xylem Inc. $XYL

Atria Investments Inc cut its holdings in Xylem Inc. (NYSE:XYL) by 22.4% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 17,874 shares of the industrial products company’s stock after selling 5,170 shares during the period. Atria Investments Inc’s holdings in Xylem were worth $2,312,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Teacher Retirement System of Texas grew its position in shares of Xylem by 1,462.5% in the first quarter. Teacher Retirement System of Texas now owns 35,516 shares of the industrial products company’s stock valued at $4,243,000 after purchasing an additional 33,243 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in Xylem by 13.6% in the 1st quarter. OneDigital Investment Advisors LLC now owns 2,863 shares of the industrial products company’s stock worth $342,000 after purchasing an additional 342 shares during the period. Wayfinding Financial LLC bought a new position in Xylem in the 1st quarter worth about $68,000. U.S. Capital Wealth Advisors LLC increased its position in shares of Xylem by 3.6% during the first quarter. U.S. Capital Wealth Advisors LLC now owns 8,153 shares of the industrial products company’s stock valued at $974,000 after buying an additional 285 shares during the period. Finally, Greenleaf Trust lifted its holdings in shares of Xylem by 5.3% in the first quarter. Greenleaf Trust now owns 7,704 shares of the industrial products company’s stock worth $920,000 after buying an additional 387 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

XYL has been the subject of several recent analyst reports. Cowen reaffirmed a “hold” rating on shares of Xylem in a research note on Tuesday, August 26th. UBS Group raised their price target on shares of Xylem from $164.00 to $168.00 and gave the company a “buy” rating in a report on Tuesday, August 5th. Mizuho set a $160.00 price target on shares of Xylem in a report on Wednesday, October 29th. Argus set a $170.00 price objective on Xylem in a research report on Wednesday, October 29th. Finally, Stifel Nicolaus boosted their target price on Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $166.20.

Insider Buying and Selling at Xylem

In other Xylem news, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares in the company, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by company insiders.

Xylem Price Performance

Shares of Xylem stock opened at $149.05 on Tuesday. The firm has a market capitalization of $36.29 billion, a PE ratio of 38.32, a price-to-earnings-growth ratio of 2.50 and a beta of 1.13. The company has a current ratio of 1.96, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The business’s 50-day moving average price is $144.86 and its 200-day moving average price is $134.83.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.Xylem’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Sell-side analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio is 41.13%.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.